RareSight Revenue
Hospitals and Health Care • 
Stadtkreis 1 Altstadt, Zurich, Switzerland • 1-10 Employees
RareSight revenue & valuation
| Annual revenue | $256,665 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Hospitals and Health Care industry and current estimated revenues | $821,328 |
| Total funding | No funding |
Key Contact at RareSight
Carsten Thiel
Co-Founder - Chief Strategy & Commercial Officer
Company overview
| Headquarters | Stadtkreis 1 Altstadt, Zurich, Switzerland |
| Website | |
| NAICS | 62 |
| Founded | 2025 |
| Employees | 1-10 |
About RareSight
RareSight is a healthtech start-up on a mission to radically shorten the diagnostic journey for people with rare diseases. Today, patients face an average diagnostic delay of 6-8 years. We believe that’s 6-8 years too long. Our AI-powered clinical decision support platform helps healthcare professionals detect rare conditions earlier by analyzing complex symptom patterns, integrating clinical data, and surfacing diagnostic suggestions grounded in the latest medical knowledge. We combine systems biology, machine learning, and clinician-friendly design to empower faster, more accurate diagnoses — and ultimately, better outcomes for patients. Currently in development, RareSight aims to launch in Switzerland by the end of Q3 2026.
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Funding Data
RareSight has never raised funding before.
South Africa
United Kingdom
United States
Spain
Netherlands
AustraliaFrequently asked questions
4.8
40,000 users
